BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Fundraising marketing - Theoria Creative - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Biotech events - Theoria Creative
X-ORIGINAL-URL:https://theoriacreative.com
X-WR-CALDESC:Events for Fundraising marketing - Theoria Creative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250318
DTEND;VALUE=DATE:20250320
DTSTAMP:20260810T150920
CREATED:20241127T164115Z
LAST-MODIFIED:20241127T164115Z
UID:11317-1742256000-1742428799@theoriacreative.com
SUMMARY:Pharma USA – Reuters Events
DESCRIPTION:Where disruption meets directionFor over two decades\, Reuters Pharma USA has been the industry’s annual check-up. This year\, we’re not just taking your temperature – we’re prescribing a full course of action. Our 2025 agenda is a potent mix of fresh perspectives\, interactive sessions\, and real-world strategies.   \nCome away with knowledge and unique information that will steer you through this inevitable change to help underpin your planning for the next week\, quarter\, year and beyond. Double down on human-led\, tech-enabled\, and data-driven strategies that steer you through the change to come. \nThis is 2025’s most important meeting for commercial\, marketing\, medical affairs\, patient engagement\, RWE\, market access and patient leaders. Don’t read about it afterwards\, be in the room.
URL:https://theoriacreative.com/calendar/pharma-usa-reuters-events-2/
LOCATION:CA
CATEGORIES:Scientific
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250324
DTEND;VALUE=DATE:20250327
DTSTAMP:20260810T150920
CREATED:20250320T093118Z
LAST-MODIFIED:20250320T093311Z
UID:11660-1742774400-1743033599@theoriacreative.com
SUMMARY:IO360° Summit
DESCRIPTION:IO360° Delivers 4 Key Benefits\n\n\n\n\n1. Delivering a 360° IO Community​ to Network and Form Collaborations\nBuild faster and more impactful collaborations with researchers\, clinicians\, biopharma leaders\, investors and policymakers to advance cancer treatments \n2. The Latest Data Driving Broader Impact\nHear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers\n​​​​​\n3. 360° Future-Focused Agenda\nStay ahead of the curve through 100+ multi-dimensional talks covering preclinical research\, translational science\, clinical development\, operational strategies\, cell therapy and business advancements \n4. 10+ Hours of Networking Opportunities\nMeet with key stakeholders in biopharma\, academia\, investors and regulatory through 1:1 meetings and scheduled functions
URL:https://theoriacreative.com/calendar/io360-summit/
LOCATION:CA
CATEGORIES:Scientific
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250325
DTEND;VALUE=DATE:20250328
DTSTAMP:20260810T150920
CREATED:20241127T164120Z
LAST-MODIFIED:20241127T164120Z
UID:11318-1742860800-1743119999@theoriacreative.com
SUMMARY:Gene Therapy for Rare Disorders Summit
DESCRIPTION:Welcome to the 8th Gene Therapy Development Summit\nTransforming the Future of Gene Therapies for Rare & Common Diseases \nWith 14 new gene therapy approvals in the last 18 months\, billion-dollar collaborations\, and the development of treatments for more common conditions\, the gene therapy field is rapidly gaining momentum and broadening scope beyond rare diseases. Returning to Boston in March\, the 8th Gene Therapy Development Summit\, formerly known as the Gene Therapy for Rare Disorders Summit\, will unite 200+ gene therapy experts to tackle the field’s biggest challenges of achieving genuine scalability and accessibility to meet growing patient demand. \nFor the first time\, this industry-defining meeting will reflect the field’s growing focus on developing therapies for common diseases\, whilst addressing existing hurdles in rare and ultra-rare disorders.
URL:https://theoriacreative.com/calendar/gene-therapy-for-rare-disorders-summit-2/
LOCATION:CA
CATEGORIES:Scientific
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250325
DTEND;VALUE=DATE:20250328
DTSTAMP:20260810T150920
CREATED:20250320T093511Z
LAST-MODIFIED:20250320T093511Z
UID:11665-1742860800-1743119999@theoriacreative.com
SUMMARY:Novel Conjugates Summit
DESCRIPTION:Pioneering Bioconjugates With Novel Payloads & Targeting Formats\n\n\n\n\n\nWe are witnessing a surging 83% growth of novel drug conjugates\, with major collaborations between Nurix & Pfizer for antibody-degrader conjugates and Bicycle & Novartis for radiopharmaceuticals. With investments booming in bispecific ADCs\, peptide drug conjugates and oligonucleotide conjugates\, the charge is on to make iterative and incremental improvements to ADCs to pave the way towards a new generation of more targeted\, safer and efficacious novel conjugated drugs. \nEncompassing the landscape of these new frontiers in targeted cancer therapy\, the 4th Novel Conjugates Summit is returning as a one-stop shop to shine a spotlight on which novel approaches are currently being explored\, what benefit each approach has\, and provide a comprehensive assessment on how you can widen your conjugate design toolkit. \nJoin us next March to find the next hottest conjugate approach as we delve into emerging data and industry-leading discussions around novel bioconjugate design and development to redefine the future of targeted cancer therapies.
URL:https://theoriacreative.com/calendar/novel-conjugates-summit/
LOCATION:CA
CATEGORIES:Scientific
END:VEVENT
END:VCALENDAR